Plain-English translation of NCT06013865 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing a medication called in veterans who have received a kidney transplant. The medication has shown promise in protecting kidneys and hearts in other patients with chronic kidney disease, but it has never been carefully studied in transplant recipients before. Researchers want to make sure this treatment is safe and effective for people like you who depend on a transplanted kidney.
After a kidney transplant, many patients eventually develop heart disease, which is a leading cause of death even when the transplanted kidney is working well. This medication has helped protect both kidneys and hearts in other kidney disease patients, but was never tested in transplant recipients because doctors worried it might harm the new kidney or interfere with anti-rejection medications. This trial aims to find out if it's actually safe and helpful for transplant patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will take one tablet by mouth once daily. The research team will monitor you carefully at multiple visits across 5 VA medical centers, watching for any side effects and checking how your transplanted kidney and heart are doing. They will collect information about your kidney function, your heart health, and any infections or other problems you experience to make sure this medication is safe for transplant patients.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States